Patents by Inventor Tracy Chow

Tracy Chow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating cancer by targeting cold tumors
    Patent number: 12357633
    Abstract: Methods are provided for the treatment of cancer or neoplastic diseases and the like, by administering 4-[2-(4-amino-piperidin-1-yl)-5-(3-fluoro-4-methoxy-phenyl)-1-methyl-6-oxo-1,6-dihydro-pyrimidin-4-yl]-2-fluoro- benzonitrile (compound of Formula (I)) or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising compounds useful for the inhibition of lysine specific demethylase-1 (LSD-1) to patients in need thereof. Methods are further drawn to administering compositions described herein to patients having neoplastic cells that express RCOR2.
    Type: Grant
    Filed: June 12, 2020
    Date of Patent: July 15, 2025
    Assignee: Celgene Corporation
    Inventors: Ellen Filvaroff, Brian Fox, Ida Aronchik, Tracy Chow
  • COMBINATION OF AN LSD-1 INHIBITOR AND NIVOLUMAB FOR USE IN TREATING SCLC OR SQNSCLC
    Publication number: 20230089536
    Abstract: The present application relates generally to a lysine specific demethylase-1 (LSD-1) inhibitor, or a pharmaceutically acceptable salt thereof, and nivolumab, for use in methods for treating small cell lung cancer (SCLC) and/or squamous non-small cell lung cancer (sqNSCLC).
    Type: Application
    Filed: March 5, 2021
    Publication date: March 23, 2023
    Applicant: Celgene Quanticel Research, Inc.
    Inventors: Ellen Filvaroff, Ida Aronchik, Tracy Chow, Eric Olson, Brian Fox, Maria Wang
  • METHODS OF TREATING CANCER BY TARGETING COLD TUMORS
    Publication number: 20220273654
    Abstract: Methods are provided for the treatment of cancer or neoplastic diseases and the like, by administering 4-[2-(4-amino-piperidin-1-yl)-5-(3-fluoro-4-methoxy-phenyl)-1-methyl-6-oxo-1,6-dihydro-pyrimidin-4-yl]-2-fluoro- benzonitrile (compound of Formula (I)) or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising compounds useful for the inhibition of lysine specific demethylase-1 (LSD-1) to patients in need thereof. Methods are further drawn to administering compositions described herein to patients having neoplastic cells that express RCOR2.
    Type: Application
    Filed: June 12, 2020
    Publication date: September 1, 2022
    Applicant: Celgene Corporation
    Inventors: Ellen Filvaroff, Brian Fox, Ida Aronchik, Tracy Chow